The paper by Wrobel et al 1 examined the efficacy of an electronic diabetes foot examination registry to aide stratification of patients into 'risk groups' and thus guides appropriate care. Convincing data exists to demonstrate that patients can be stratified into groups at higher or lower risk of subsequent ulceration/ amputation.2 The stratification tools largely rely on detailed examination findings (neuropathy, peripheral artery disease, abnormalities of foot shape). What is less clear is whether these risk stratification schemes can be successfully translated into effective population based screening.
Findings may be limited by lack of standardisation and wide testingWrobel et al demonstrated that implementation of a new electronic registry system improved risk profiling of patients with diabetes-related foot disease. However, the study has a number of limitations. Foot examinations between centres were not standardised and were performed by a range of health care practitioners in different health care settings thus confounding outcomes. The new registry system was only trialled at one centre, limiting the generaliseablity of results. Nevertheless the principles of the system and general methodology behind the study were sound and warrant further assessment in different settings.